JPS5649335A - Ether compound - Google Patents

Ether compound

Info

Publication number
JPS5649335A
JPS5649335A JP8764580A JP8764580A JPS5649335A JP S5649335 A JPS5649335 A JP S5649335A JP 8764580 A JP8764580 A JP 8764580A JP 8764580 A JP8764580 A JP 8764580A JP S5649335 A JPS5649335 A JP S5649335A
Authority
JP
Japan
Prior art keywords
ether compound
ether
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP8764580A
Other languages
English (en)
Other versions
JPH0154339B2 (ja
Inventor
Kuniin Jiyofurei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of JPS5649335A publication Critical patent/JPS5649335A/ja
Publication of JPH0154339B2 publication Critical patent/JPH0154339B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125—Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/74—Unsaturated compounds containing —CHO groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
JP8764580A 1979-06-29 1980-06-27 Ether compound Granted JPS5649335A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7922781 1979-06-29

Publications (2)

Publication Number Publication Date
JPS5649335A true JPS5649335A (en) 1981-05-02
JPH0154339B2 JPH0154339B2 (ja) 1989-11-17

Family

ID=10506199

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8764580A Granted JPS5649335A (en) 1979-06-29 1980-06-27 Ether compound

Country Status (18)

Country Link
US (1) US4410537A (ja)
EP (1) EP0022229B1 (ja)
JP (1) JPS5649335A (ja)
KR (2) KR850000073B1 (ja)
AU (1) AU545274B2 (ja)
DE (1) DE3061269D1 (ja)
DK (1) DK159770C (ja)
FI (1) FI71929C (ja)
GB (1) GB2053218B (ja)
GR (1) GR68748B (ja)
HU (1) HU190774B (ja)
IL (1) IL60422A (ja)
IT (1) IT1133025B (ja)
MW (1) MW2380A1 (ja)
OA (1) OA06699A (ja)
ZA (1) ZA803880B (ja)
ZM (1) ZM5780A1 (ja)
ZW (1) ZW14480A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003513060A (ja) * 1999-11-05 2003-04-08 エミスフェアー・テクノロジーズ・インク フェノキシカルボン酸化合物及び活性剤を送達するための組成物
JP2016516696A (ja) * 2013-03-15 2016-06-09 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンの修飾のための化合物及びその使用

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU190371B (en) * 1980-12-18 1986-08-28 The Wellcome Foundation Ltd,Gb Process for producing ether-type compounds and pharmaceutical compositions containing them as active agents
GB8606913D0 (en) * 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
WO1998030141A2 (en) 1997-01-09 1998-07-16 Cohesion Technologies, Inc. Devices for tissue repair and methods for preparation and use thereof
US7129274B1 (en) 1999-11-05 2006-10-31 Emisphere Technologies Inc. Phenoxy carboxylic acid compounds and compositions for delivering active agents
US7279597B1 (en) 1999-11-05 2007-10-09 Emisphere Technologies, Inc. Phenyl amine carboxylic acid compounds and compositions for delivering active agents
AU2001245823A1 (en) * 2000-03-17 2001-10-03 Corixa Corporation Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
US8246969B2 (en) 2001-11-16 2012-08-21 Skinmedica, Inc. Compositions containing aromatic aldehydes and their use in treatments
AU2012204164A1 (en) 2011-01-07 2013-07-25 Allergan, Inc. Melanin modification compositions and methods of use
PT3738434T (pt) 2011-12-28 2023-11-13 Global Blood Therapeutics Inc Intermediários para obter compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
ES2790358T3 (es) 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
CA2902711C (en) 2013-03-15 2021-07-06 Global Blood Therapeutics, Inc. Substituted pyridinyl-6-methoxy-2-hydroxybenzaldehyde derivatives and pharmaceutical compositions thereof useful for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
CN111454200A (zh) 2013-03-15 2020-07-28 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EP3036222A2 (en) * 2013-08-23 2016-06-29 Virginia Commonwealth University Ester nitrates derivatives of aromatic aldehydes with multiple pharmalogic properties to treat sickle cell disease
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
SI3102208T1 (sl) 2014-02-07 2021-07-30 Global Blood Therapeutics, Inc. Kristalinični polimorf proste baze 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-IL)piridin-3-IL)metoksi)- benzaldehida
MY190034A (en) 2015-03-06 2022-03-22 Beyondspring Pharmaceuticals Inc Method of treating cancer associated with a ras mutation
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
MY192703A (en) * 2016-02-08 2022-09-02 Beyondspring Pharmaceuticals Inc Compositions containing tucaresol or its analogs
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3768264A4 (en) * 2018-03-22 2021-12-22 Virginia Commonwealth University AROMATIC ALDEHYDE WITH DELAYED AND IMPROVED PHARMACOLOGICAL IN-VITRO AND IN-VIVO ACTIVITY FOR TREATMENT OF SICKLE CELL DISEASE
US11014884B2 (en) 2018-10-01 2021-05-25 Global Blood Therapeutics, Inc. Modulators of hemoglobin
JP2022509091A (ja) 2018-11-19 2022-01-20 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンのモジュレーター

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU36787A1 (ja) * 1958-04-30
CH543472A (fr) * 1969-01-31 1973-10-31 Orchimed Sa Procédé pour la préparation d'acides phénoxyalcoyl-carboxyliques
DE2209128C3 (de) 1971-03-05 1981-10-22 CIBA-GEIGY AG, 4002 Basel Bis-Stilbenverbindungen, Verfahren zu deren Herstellung und deren Verwendung als optische Aufheller
CH550776A (de) 1971-03-05 1974-06-28 Ciba Geigy Ag Herstellung neuer bis-stilbenverbindungen.
GB1511645A (en) 1974-05-31 1978-05-24 Univ Ife Sickle cell anaemia treatment
US4137309A (en) * 1976-10-14 1979-01-30 The Procter & Gamble Company Therapeutic treatment

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003513060A (ja) * 1999-11-05 2003-04-08 エミスフェアー・テクノロジーズ・インク フェノキシカルボン酸化合物及び活性剤を送達するための組成物
JP2016516696A (ja) * 2013-03-15 2016-06-09 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンの修飾のための化合物及びその使用
JP2020105228A (ja) * 2013-03-15 2020-07-09 グローバル ブラッド セラピューティクス インコーポレイテッド ヘモグロビンの修飾のための化合物及びその使用

Also Published As

Publication number Publication date
KR830002693A (ko) 1983-05-30
GB2053218A (en) 1981-02-04
ZM5780A1 (en) 1983-11-21
DK279780A (da) 1980-12-30
MW2380A1 (en) 1982-03-10
HU190774B (en) 1986-11-28
DK159770B (da) 1990-12-03
DE3061269D1 (en) 1983-01-13
ZA803880B (en) 1982-02-24
KR850000072B1 (ko) 1985-02-18
IT1133025B (it) 1986-07-09
KR850000073B1 (ko) 1985-02-18
GR68748B (ja) 1982-02-16
AU545274B2 (en) 1985-07-11
KR840004668A (ko) 1984-10-22
EP0022229B1 (en) 1982-12-08
AU5969780A (en) 1981-01-08
IL60422A0 (en) 1980-09-16
OA06699A (fr) 1982-05-31
EP0022229A1 (en) 1981-01-14
JPH0154339B2 (ja) 1989-11-17
FI802052A (fi) 1980-12-30
ZW14480A1 (en) 1982-03-17
IT8049108A0 (it) 1980-06-27
GB2053218B (en) 1984-01-25
DK159770C (da) 1991-04-22
FI71929B (fi) 1986-11-28
FI71929C (fi) 1987-03-09
IL60422A (en) 1984-06-29
US4410537A (en) 1983-10-18

Similar Documents

Publication Publication Date Title
JPS5649335A (en) Ether compound
JPS54119486A (en) 66substituted thiaaaza compound
GB2052478B (en) Guanidinothiazole compounds
JPS5594363A (en) Phenoxyphenylpiperidine compound
GB2025999B (en) Bistrialkoxysiloxy - silane compound
JPS5610183A (en) 199hydroxyypgi compound
JPS5686134A (en) Eicosapentanoate compound
JPS55124743A (en) 99aminoalkylfluorene compound
JPS55143971A (en) 144methoxymorphinann66one compound
JPS55111255A (en) Compound structure
JPS56113779A (en) Compound
GB2125037B (en) 2-acetoxymethyl-penam compounds
ZA806146B (en) Heterocyclici compounds
JPS55136288A (en) Betaalactam contained compound
JPS567790A (en) Novel penicillinn1*11dioxide compound
JPS5594364A (en) Phenylthiophenylpiperidine compound
JPS5667369A (en) Phthaloperinone compound
JPS55113769A (en) 44substitutedd22iminoimidazolidine compound
GB2047708B (en) Butyloctyl-magnesium compounds
JPS55136264A (en) Pyridineacetoamide compound
JPS55124648A (en) Compound structure
JPS55147293A (en) Novel thiazolinoazetidinone compound
IL61133A0 (en) 6-methylene-morphinan compounds
JPS56100858A (en) Halootriazinyl compound
JPS5632575A (en) Antiifreeze compound